MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

256.10 +2.72 (+1.07%)
Streaming Delayed Price Updated: 12:22 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,171,804
Open 253.70
Bid (Size) 256.04 (200)
Ask (Size) 256.15 (100)
Prev. Close 253.38
Today's Range 252.60 - 257.06
52wk Range 184.63 - 261.63
Shares Outstanding N/A
Dividend Yield 2.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PJP vs. IYH: Which Healthcare ETF Is the Better Buy? ↗
PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? ↗
There's no need to panic. 
Via The Motley Fool

Performance

YTD
+11.7%
+11.7%
1 Month
+11.3%
+11.3%
3 Month
+25.7%
+25.7%
6 Month
+19.6%
+19.6%
1 Year
+38.5%
+38.5%

More News

Read More
News headline image
My 2 Favorite Dividend Kings to Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation ↗
Via Chartmill
Topics Cannabis
News headline image
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
3 Rock-Solid Dividend Stocks to Buy and Hold for Decades ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb ↗
Via The Motley Fool
Topics Government Intellectual Property
News headline image
3 Dividend Stocks Built for Long-Term Buy-and-Hold Investors ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
5 Dividend Kings to Buy in July with Irristable Value and Yield ↗
Via MarketBeat
News headline image
3 Reasons to Buy Novo Nordisk Stock ↗
Via The Motley Fool
News headline image
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend ↗
Via The Motley Fool
News headline image
Abivax: Wall Street Catches Up to the Data ↗
Via MarketBeat
News headline image
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Dividend ETF Quietly Outperforming the S&P 500 ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Is Apple Stock a Buy After Its Recent Pullback? Here's What History Suggests. ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Market-Beating Stocks Worth Investigating
Via StockStory
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway. ↗
Via Chartmill
News headline image
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
From Biotech Insider
Via GlobeNewswire
News headline image
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy? ↗
Via The Motley Fool
News headline image
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
Via StockStory
Topics Retirement Stocks

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 256.10
When was AbbVie last traded?
The last trade of AbbVie was at 07/21/26 12:22 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story